Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 17 Jul 2026 for Catalyst Pharmaceuticals, INC., €114.9M. Read the official filing
Filing timeline
BuySalePatrick J. Mcenany
Insider track record
Disclosed buys
0
Disclosed sells
2
Signal history
Patrick J. Mcenany: trading record in brief
Patrick J. Mcenany (chief executive) discloses dealings in Catalyst Pharmaceuticals, Inc. to SEC (Form 4). Between 13 August 2021 and 15 July 2026, the trades on record add up to 26 filings.
Sales make up the whole of the open-market record (2 sales, €1.9M). Besides market trades, the filings include 1 share grant and 18 option exercises.
On 17 July 2026 came the latest disclosure, a transaction for €114.9M in Catalyst Pharmaceuticals, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Patrick J. Mcenany
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
4,171,559 shares@ US$31.503.39% mcap95.9% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-26-000179:0
26,334 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000493:0
6,786 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000493:1
3,534 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000447:0
45,000 shares0Common stock, par value $0.001 per shareSEC:0001161697-25-000432:0
1,775 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000419:0
28,252 shares@ US$25.9450.5% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-25-000185:0
3,533 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000504:0
98,345 shares@ US$3.540.3% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000457:0
92,500 shares@ US$3.540.3% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000447:0
230,000 shares@ US$4.010.7% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000445:0
5,100 shares0Common Stock, par value $0.001 per shareSEC:0001161697-24-000377:0
45,000 shares0Common Stock, par value $0.001 per shareSEC:0001161697-24-000362:0
26,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000055:0
250,000 shares@ US$1.130.2% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000025:0
26,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000649:0
26,151 shares@ US$0.790.0% of flowCommon stock, par value $0.001 per shareSEC:0001161697-23-000300:0
58,333 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000131:0
10,000 shares0Common stock, par value $0.001 per shareSEC:0001161697-22-000615:0
30,834 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-22-000575:0
350,000 shares@ US$2.240.6% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000556:0
80,765 shares@ US$15.3291.0% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000457:0
25,000 shares@ US$2.530.1% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000399:0
30,833 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-21-000565:0
80,000 shares@ US$3.120.2% of flowCommon stock, par value $0.001 per shareSEC:0001161697-21-000406:0
25 of 26 declarations
